Infant Bacterial Therapeutics AB (publ) reported earnings results for the fourth quarter and year ended December 31, 2020. For the quarter, operating loss was SEK 26,702,000 against SEK 27,428,000 a year ago. Loss after tax was SEK 26,726,000 against SEK 27,535,000 a year ago. Loss per share before and after dilution was SEK 2.38 against SEK 2.45 a year ago. For the year, operating loss was SEK 71,918,000 against SEK 47,200,000 a year ago. Loss after tax was SEK 72,007,000 against SEK 46,320,000 a year ago. Loss per share before and after dilution was SEK 6.41 against SEK 4.13 a year ago.